The decision comes as Pfizer faces lawsuits from more than 1000 women who say the company knew about the risks and didn’t warn them. The agency signed off last week on a label update for 2 versions of ...

As of 2025, lawsuits are now underway against Pfizer, the manufacturer of Depo-Provera, filed by women who were diagnosed with meningioma after using the birth control shot. These cases allege that ...

Depo Provera Brain Tumor: Medroxyprogesterone acetate, a contraceptive injection containing the hormone progestin, is widely known by its brand name, Depo-Provera. Administered every three months, it ...

Some women report "nightmare" symptoms when stopping birth control injections. Oct. 26, 2009— -- For 15 years, Kae Guardi loved her Depo-Provera, taking injections of the synthetic birth control ...

Women injected with the Depo-Provera birth control shot are more than five-times more likely to be diagnosed with a type of brain tumors known as meningioma, according to a recent study. Several ...

At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, ...

If you’ve experienced serious side effects after using Depo-Provera, you are not alone. The birth control injection has been linked to a range of adverse health effects, including bone density loss, ...

Depo-Provera is an injectable form of birth control. Bleeding and changes to menstrual flow are common during the first year of use. However, bleeding after using Depo-Provera typically resolves ...

Sex-iversity is a question and answer column designed to provide important information and answers to questions regarding sex, sexuality, sexual orientation, sexually transmitted infections and ...

Pfizer site manufacturing heparin active pharmaceutical ingredient. Pfizer is a pharmaceutical biotechnology corporation. U.S. government regulators have approved a new brain tumor warning for ...

FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot THURSDAY, Dec. 18, 2025 (HealthDay News — The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a ...